Implementing a Randomized Control Trial to Test the Expanded Web-based Decision Aid
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWashington University School of Medicine
About this trial
The overall goal of the randomized control trial (RCT) will be to evaluate the efficacy of modifications to a web-based tool for patient decision-making regarding return of genomic results that will more closely focus on rare cancers. Participants will be given access to a web-based decision aid (or a standard control) that guides participants in making decisions about what type of genomic results they would like to receive from testing performed in the PE-CGS study (NCT06340646).
Eligibility criteria
Qualifiers
Diagnosis of cholangiocarcinoma
Diagnosis of multiple myeloma, must be African American
Diagnosis of colorectal cancer, must be African American and age 65 or older at time of diagnosis
At least 18 years old.
Disqualifiers
None
Trial design
Treatments tested in this trial
- Standard developed materials
- Genetics Advisor Decision Aid
Treatment groups
240 Participants
are divided into 2 treatment groupsSponsors and collaborators
Washington University School of Medicine
Lead sponsor
National Cancer Institute (NCI)
Collaborator
Source ClinicalTrials.gov